INTRODUCTION {#sec1-1}
============

Infectious mononucleosis (IM), sometimes referred to as the kissing disease, is considered a benign, self-limited lymphoproliferative disorder due to the exposure to Epstein--Barr virus (EBV) or cytomegalovirus,\[[@ref1]\] which usually courses as an asymptomatic infection, especially among children when they first become exposed to the virus. On the other hand, infections on the unexposed adult represent a greater risk for developing a symptomatic disease, and after infection, the patient remains as a reservoir for EBV for life.\[[@ref2][@ref3]\]

Spreading of the virus usually occurs through fomites contaminated with saliva or more frequently through kissing. In adults, 90% of the population is considered carrier of the virus, having detectible EBV antibodies in serum. When developing a symptomatic course, the most common clinical presentation of IM is characterized by pharyngitis, tonsillitis, lymph node enlargement (typically affecting cervical lymph nodes), fatigue and pyrexia.\[[@ref2][@ref4][@ref5]\] Other complications related to the infection include splenomegaly and hepatomegaly, and in some instances, soft palate petechiae may be an intraoral finding.\[[@ref6]\] These signs and symptoms can lead the practitioner to a diagnosis of IM, and proper serological tests to confirm are needed.\[[@ref7]\]

Sometimes, IM may present itself as a rather difficult entity to diagnose due to unusual clinical presentations. Taga *et al*. reported 17 atypical cases of IM, showing none or only one of the classic signs or symptoms, and even so, some of the chief complaints were otitis media, gastroenteritis, fatigue or cough; therefore, the attending physicians failed to suspect of IM.\[[@ref4]\] Nishikawa described a case of a 34-year-old man with IM, whose main symptoms were fever, fatigue and loss of appetite, symptoms that are nonspecific and thus making the initial diagnosis of IM difficult.\[[@ref8]\] Herein, we report a case of IM with an atypical presentation on a young female patient.

CASE REPORT {#sec1-2}
===========

A 21-year-old caucasian female was referred to our service with a left preauricular nodular mass at the temporomandibular joint level. According to the patient, it was persistent in growth and had been developing for a period of 2 weeks and a half. At physical examination, the clinical presentation of the lesion was of a round, asymptomatic, well-defined, firm and movable mass \[[Figure 1](#F1){ref-type="fig"}\] with 2 cm in diameter. During palpation, two other lymph node enlargements were discovered, one in the submandibular region and the other on the mid cervical portion of the sternocleidomastoid muscle, both on the left side. The skin overlying these nodules was of normal appearance. The patient also referred having sporadic tearing out of her left eye. Intraoral examination revealed diffuse petechiae on the soft palate. No other signs or symptoms were recorded. At this point, IM, toxoplasmosis and a lymphoma were considered within the possible diagnosis.

![Preauricular lymph node enlargement](JOMFP-24-139-g001){#F1}

A computed tomography scan was requested, revealing lymph node enlargements of the left preauricular and submandibular areas \[[Figure 2](#F2){ref-type="fig"}\], along with multiple small enlargements of the posterior cervical lymph nodes. A cytology examination by fine needle aspiration (FNA) was performed, resulting in sheets of normal lymphoid cells, including lymphoblasts, small lymphocytes and centroblasts \[[Figure 3](#F3){ref-type="fig"}\].

![Axial computed tomography section showing an isodense nodular encapsulated enlargement (arrow) in the preauricular region](JOMFP-24-139-g002){#F2}

![Fine needle aspiration smear demonstrating sheets of lymphoblasts surrounded by small lymphocytes (Giemsa stain, ×100)](JOMFP-24-139-g003){#F3}

The blood tests were normal, and HIV test came in negative. Antibodies for toxoplasmosis were also tested, but the results were not conclusive. Immunoglobulin (Ig) G and IgM antibodies for EBV both turned in positive \[[Table 1](#T1){ref-type="table"}\]. The patient confirmed having had IM 12 months before.

###### 

Hepatic function tests and Epstein-Barr virus (EBV) enzyme immunoassay

  Measured parameter        Patient's results   Normal values
  ------------------------- ------------------- -----------------
  Total Bilirubin           0.3 mg/dL           0.2-1.3
  Direct Bilirubin          0.1 mg/dL           0-0.3
  Indirect Bilirubin        0.2 mg/dL           
  Total Alkalinity          39.0 U/L            38-126
  GOT Transaminase          21 U/L              14-36
  GPT Transaminase          27 U/L              9-52
  G. Glutamil Transferase   18 U/L              12-43
  C Reactive Protein        0.9 mg/L            0-10
  EBV IgM                   \>50 U              Positive \>11.0
  EBV IgG                   14.8 U              Positive \>11.0

A treatment consisting of ketoprofen was given to the patient, and by the 6^th^ week, the lymph node enlargements began to reduce in size, and finally to a clinical normal state. No further treatment was indicated. With the resolution of these nodular enlargements, the cytological results and the patient being positive for EBV IgM antibodies, a definitive diagnosis of a reactivation of IM was made.

DISCUSSION {#sec1-3}
==========

IM is caused by EBV on 84%--95% of the cases,\[[@ref1][@ref3]\] and it is characterized by pyrexia, pharyngitis, lymphadenopathies and the observation of atypical lymphocytes in blood smears.\[[@ref2][@ref4][@ref5]\] Usually asymptomatic in children, IM symptoms become more prevalent with age, and in developed countries, teenagers and college students are at a greater risk of infection because this virus is transmitted through saliva, hence the name "kissing sisease." In younger patients and children, fomites contaminated with saliva carrying the virus are the main vector of transmission.\[[@ref5][@ref6]\] Blood transfusions and bone marrow transplants have been occasionally implicated in the transmission of EBV.\[[@ref9][@ref10]\]

Once the virus enters the oropharynx, it infects and replicates on epithelial and acinar cells. Later, B-cells become the main target, mainly because EBV shows a tropism for the CD21 coreceptor on the B-cell surface; the production of virions capable of infecting more cells continues, and consequently, the spreading of the virus via blood stream is accomplished.\[[@ref3]\] Lymphoid organs are compromised by the infection, and clinically the patient may develop cervical lymphadenopathies and splenomegaly.\[[@ref1]\] T-cytotoxic cells are the main suppressors against the infection; therefore, if the immunity of the patient is compromised, the virus can proliferate in an uncontrolled manner, causing other types of more serious pathologies such as Burkitt\'s and Hodgkin\'s lymphoma.\[[@ref11][@ref12]\] The virus can infect the patient for life by establishing latency in memory B-cells, evading the immune system.\[[@ref3]\]

When a patient develops the classic signs and symptoms discussed above, the practitioner is usually able to gather these findings and lead a plausible diagnosis toward IM; at this point, serological tests can be requested to confirm this suspicion.\[[@ref7][@ref13]\] However, cases of patients with IM coursing with an atypical clinical presentation may make the diagnosis process difficult, and this could result in lymph node excision. Further histopathological studies of the biopsy showing an immunoblastic proliferation could accelerate an erroneous diagnosis of a malignant lymphoma.\[[@ref14][@ref15]\] Immunohistochemical analysis has proven to be a resourceful tool to confirm or reject a monoclonal cell proliferation.\[[@ref14]\] Atypical manifestations of IM are detailed in [Table 2](#T2){ref-type="table"}.

###### 

Atypical symptoms in IM patients reported by other authors (2,5,3,10,11,12,13,14,15)

  --------------------------------------------------------------------------------------------------------------------------
  Author                         Signs and Symptoms
  ------------------------------ -------------------------------------------------------------------------------------------
  Martin, M (1977)               Bone marrow granulomas, fever, malaise, headache and weight loss

  McKendrick (1979)              Patient 1: Fever, sweating, dry cough. Patient 2: Fatigue, fever

  Freedman, B. (1980)            Painful gingivitis, low fever, atypical lymphocytes (blood smear)

  Kato, H. *et al* (1993)        Exanthema, sore throat, bilateral cervical lymph node enlargement

  Kojima M. *et al* (2002)       Non-tender cervical and inguinal lymph node enlargement, lymph node infarction, low fever

  Fujiwara, M. *et al* (2009)    Gastroenteritis, fever, diarrhea, nausea

  Fusilli, G. (2010)             Leucopenia, pharyngitis, fever

  Nishikawa, J. *et al* (2011)   Non-tender lymph node enlargements, mild hepatosplenomegaly, fever and fatigue.

  Taga, K. *et al* (2016)        Patient 1: Fever\
                                 Patient 2: Cough\
                                 Patient 3: Fever, cough\
                                 Patient 4: Fever, cough\
                                 Patient 5: Fever, diarrhea\
                                 Patient 6: Low fever\
                                 Patient 7: Skin eruption\
                                 Patient 8: Cough\
                                 Patient 9: Fatigue, headache\
                                 Patient 10: Epigastric discomfort\
                                 Patient 11: Malaise, pharyngitis, abdominal pain\
                                 Patient 12: Fever, cough, vomiting, diarrhea\
                                 Patient 13: Fever\
                                 Patient 14: Fever, cough, skin eruption\
                                 Patient 15: Cough, pharyngitis\
                                 Patient 16: Lymphadenopathy, cough, rhinorrhea\
                                 Patient 17: Fever
  --------------------------------------------------------------------------------------------------------------------------

Usually, FNA cytology (FNAC) is not necessary to diagnose IM; however, in atypical cases, it could be used to rule out the suspicion of lymphoma, in association with blood tests. Stanley *et al*. showed in FNAC that the array of cells that can be observed through this method ranges from lymphohistiocytic aggregates, loose granulomatous formations of epithelioid histiocytes with abundant pale staining cytoplasm, a spectrum of immunoblast maturation toward mature plasma cells to the observance of sheets composed of centroblasts and plasma cells.\[[@ref16]\] In our case, the FNAC was needed to rule out lymphoma, mainly because the clinical and imaging results were not conclusive. The cytological characteristics we observed are similar to those described by other authors,\[[@ref16]\] as the presence of lymphoblasts and immunoblasts surrounded by lymphocytes of smaller size along with a mixed inflammatory infiltrate including neutrophils, suggesting an acute reactive process.

Lymph node enlargements with absent signs of infection such as tenderness and pain, redness, a local raise of temperature and general malaise and pyrexia could represent a diagnostic challenge. In this case, the only measurable sign was that of the lymph node enlargements, and this could have easily directed our diagnosis toward a neoplasm of lymphoid nature. The blood test results came in normal, except for the enzyme immunoassay for EBV IgG and IgM antibodies, proving an atypical EBV reactivation on the patient. Treatment of IM is merely supportive consisting of symptom relief with nonsteroid anti-inflammatory drugs and liquid intake.\[[@ref8]\]

According to the clinical, imaging and cytological features and the positive results of the enzyme immunoassay for EBV IgG and IgM antibodies, the current case was diagnosed as an IM reactivation due to EBV. In conclusion, atypical manifestations of IM are rare and difficult to diagnose, being necessary to discard the differential diagnosis with complementary examinations before carrying on to the definitive diagnosis.
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